MedPath

The optimal ultrafiltration method in cell-free and concentrated ascites reinfusion therapy

Not Applicable
Conditions
Patients with refractory cancerous ascites
Registration Number
JPRN-UMIN000025382
Lead Sponsor
Fujita Health University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
9
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with ascites contaminated by endotoxin 2. Severe immunocompromized patients 3. Patients who have peritoneo-venous shunt 4. Patients who have transjugular intrahepatic portosystemic shunt 5. Infection; Syphilis HBs antigen HBc antibody HCV HIV01,2 HTLV1 6. Patients who are judged as the inappropriate for this study by the doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The time to reach the set pressure (TMP500mmHg)
Secondary Outcome Measures
NameTimeMethod
1. The serial change of transmembrane pressure and ascites weight 2. Analysis of the original ascites and the filtered ascites 3. Analysis of the filter
© Copyright 2025. All Rights Reserved by MedPath